180 Wealth Advisors’s CalciMedica CALC Stock Holding History

180 Wealth Advisors’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.9K	Sell	83,400 -43,100	-34%	-$30.5K	0.01%	478
2026 Q1	$68.3K	Buy	126,500 +94,650	+297%	+$192K	0.01%	467
2025 Q4	$210K	Sell	31,850 -10,850	-25%	-$42.3K	0.02%	440
2025 Q3	$131K	Sell	42,700 -7,750	-15%	-$22.3K	0.02%	441
2025 Q2	$80.7K	Buy	50,450 +34,050	+208%	+$58.5K	0.01%	416
2025 Q1	$31.3K	Buy	+16,400	New	+$40.9K	0.01%	410

180 Wealth Advisors's CALC Position: Q2 2026 in Review

180 Wealth Advisors reduced its CalciMedica (CALC) stake by 34% in Q2 2026, selling an estimated $30.5K and leaving 83,400 shares worth $85.9K. The position accounts for 0.01% of the portfolio, ranked #478.

180 Wealth Advisors first reported a position in CALC in Q1 2025 and has held it in 6 quarters since. The position peaked at $210K in Q4 2025. 1 fund tracked by Wall St. Rank holds CALC as of Q2 2026.

180 Wealth Advisors held 83,400 shares of CalciMedica worth $85.9K as of Q2 2026.
180 Wealth Advisors sold 43,100 CalciMedica shares in Q2 2026, an estimated $30.5K.
CalciMedica made up 0.01% of 180 Wealth Advisors's portfolio in Q2 2026, its #478 holding.
180 Wealth Advisors first reported a position in CalciMedica in Q1 2025 and has held it in 6 quarters since.
180 Wealth Advisors's CalciMedica position peaked at $210K in Q4 2025.
1 fund tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.